Zydus Cadila gets tentative nod from USFDA to market cancer drug
Zydus Cadila gets tentative nod from USFDA to market cancer drug The company has received tentative approval from the United States Food and Drug Administration (USFDA) to market Ibrutinib tablets, in the strengths of 140 mg, 280 mg, 420 mg and 560 mg, Zydus Cadila said in a statement. https://ift.tt/eA8V8J
Lifting Weights? Your Fat Cells Would Like to Have a Word
Lifting Weights? Your Fat Cells Would Like to Have a Word
https://ift.tt/3wZl3pL July 21, 2021 at 05:03PM https://ift.tt/1R552o9
 |
submitted by /u/Maxcactus [link] [comments] |
Blood test CoviRisk TBNK to identify the risk status of COVID-19 patient
Blood test CoviRisk TBNK to identify the risk status of COVID-19 patient The new diagnostic test can identify the severity and prognosis, in triaging of hospitalised COVID-19 patients, and helps to determine if a patient might require IMV and ICU facility https://ift.tt/eA8V8J
U.S. Life Expectancy Fell By 1.5 Years In 2020, The Biggest Drop Since WWII
U.S. Life Expectancy Fell By 1.5 Years In 2020, The Biggest Drop Since WWII
https://ift.tt/3kGHC0i July 21, 2021 at 03:29PM https://ift.tt/1R552o9
 |
submitted by /u/Maxcactus [link] [comments] |
Subscribe to:
Posts (Atom)